Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.

Naseem A, Hussain Y, Ahmad B, Aziz MT, Ahmad M, Hameed H.

J Pak Med Assoc. 2011 Jan;61(1):18-22.

2.

Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.

Montalar J, Segura A, Bosch C, Galan A, Juan O, Molins C, Giner V, Aparicio J.

Med Oncol. 2002;19(3):161-6.

PMID:
12482126
3.

Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.

Fleming DR, Ziegler C, Baize T, Mudd L, Goldsmith GH, Herzig RH.

Am J Clin Oncol. 2003 Jun;26(3):285-8.

PMID:
12796602
4.

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.

Shenep JL, Hughes WT, Roberson PK, Blankenship KR, Baker DK Jr, Meyer WH, Gigliotti F, Sixbey JW, Santana VM, Feldman S, et al.

N Engl J Med. 1988 Oct 20;319(16):1053-8.

PMID:
3050517
5.

Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.

Chuang YY, Hung IJ, Yang CP, Jaing TH, Lin TY, Huang YC.

Pediatr Infect Dis J. 2002 Mar;21(3):203-9.

PMID:
12005083
6.

[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].

Marie-Cardine A, Schneider P, Blot N, Tron P, Vannier JP.

Arch Pediatr. 2003 Apr;10(4):307-12. French.

PMID:
12818750
7.

Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.

Kwon KT, Cheong HS, Rhee JY, Wi YM, Ryu SY, Heo ST, Moon CS, Ki HK, Kim KH, Jung CW, Peck KR, Song JH.

Jpn J Clin Oncol. 2008 Jan;38(1):49-55. doi: 10.1093/jjco/hym151. Epub 2008 Jan 17.

8.
10.

[Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].

Zikesoá E, Hnátková M, Vacková B, Jedlicková A, Klener P, Trnený M.

Cas Lek Cesk. 2006;145(5):383-6, 388-9. Czech.

PMID:
16755776
11.

Cefepime monotherapy for treatment of febrile neutropenia in children.

Ariffin H, Ai CL, Lee CL, Abdullah WA.

J Paediatr Child Health. 2006 Dec;42(12):781-4.

PMID:
17096713
12.

Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.

Petrilli AS, Cypriano M, Dantas LS, Lee LM, Vercillo Luisi MF, Torres B Silva KV, Pires Pereira CA.

Braz J Infect Dis. 2003 Apr;7(2):111-20.

13.

Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.

Sanz MA, López J, Lahuerta JJ, Rovira M, Batlle M, Pérez C, Vázquez L, Julià A, Palau J, Gutiérrez M, Capote FJ, Ramos F, Benlloch L, Larrea L, Jarque I; Spanish PETHEMA Group.

J Antimicrob Chemother. 2002 Jul;50(1):79-88.

14.

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.

Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D.

Am J Med. 1996 Jun 24;100(6A):83S-89S.

PMID:
8678102
15.

Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.

Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV.

Cancer. 2003 Sep 1;98(5):1039-47.

16.

Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.

Erman M, Akova M, Akan H, Korten V, Ferhanoğlu B, Köksal I, Cetinkaya Y, Uzun O, Unal S; Febrile Neutropenia Study Group of Turkey.

Scand J Infect Dis. 2001;33(11):827-31.

PMID:
11760163
17.

Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.

Kebudi R, Görgün O, Ayan I, Gürler N, Akici F, Töreci K.

Med Pediatr Oncol. 2001 Apr;36(4):434-41.

PMID:
11260566
18.

Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.

Mustafa MM, Carlson L, Tkaczewski I, McCracken GH Jr, Buchanan GR.

Pediatr Infect Dis J. 2001 Mar;20(3):362-9. Review.

PMID:
11303851
19.

Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.

Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ.

Clin Infect Dis. 1997 Jan;24(1):41-51.

20.

Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.

Hamidah A, Lim YS, Zulkifli SZ, Zarina AL, Nordiah AJ, Jamal R.

Singapore Med J. 2007 Jul;48(7):615-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk